Document Detail

OptEase and TrapEase vena cava filters: a single-center experience in 258 patients.
MedLine Citation:
PMID:  19449061     Owner:  NLM     Status:  MEDLINE    
We aimed to evaluate the efficacy and safety of the OptEase and TrapEase (both from Cordis, Roden, Netherlands) vena cava filters in the prevention of pulmonary embolism (PE). Between May 2004 and December 2008, OptEase (permanent/retrievable; n = 228) or TrapEase (permanent; n = 30) vena cava filters were placed in 258 patients (160 female and 98 male; mean age 62 years [range 22 to 97]). Indications were as follows: prophylaxis for PE (n = 239), contraindication for anticoagulation in the presence of PE or DVT (n = 10), and development of PE or DVT despite anticoagulation (n = 9). Medical records were retrospectively reviewed for indications, clinical results, and procedure-related complications during placement and retrieval. Clinical PE did not develop in any of the patients. However, radiologic signs of segmental PE were seen in 6 of 66 patients with follow-up imaging data. Migration or fracture of the filter or cava perforation was not seen in any of the patients. Except for a single case of asymptomatic total cava thrombosis, no thrombotic occlusion was observed. One hundred forty-one patients were scheduled to undergo filter removal; however, 17 of them were not suitable for such based on venography evaluation. Removal was attempted in 124 patients and was successful in 115 of these (mean duration of retention 11 days [range 4 to 23]). Nine filters could not be removed. Permanent/retrievable vena cava filters are safe and effective devices for PE prophylaxis and for the management of venous thromboembolism by providing the option to be left in place.
Levent Onat; Ali Kursat Ganiyusufoglu; Ayhan Mutlu; Mustafa Sirvanci; Cihan Duran; Onur Levent Ulusoy; Azmi Hamzaoglu
Publication Detail:
Type:  Journal Article     Date:  2009-05-16
Journal Detail:
Title:  Cardiovascular and interventional radiology     Volume:  32     ISSN:  1432-086X     ISO Abbreviation:  Cardiovasc Intervent Radiol     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-04     Completed Date:  2009-12-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8003538     Medline TA:  Cardiovasc Intervent Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  992-7     Citation Subset:  IM    
Department of Radiology, Florence Nightingale Hospital, Istanbul, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Chi-Square Distribution
Device Removal
Equipment Safety
Middle Aged
Pulmonary Embolism / prevention & control*
Retrospective Studies
Tomography, X-Ray Computed
Treatment Outcome
Vena Cava Filters* / adverse effects
Venous Thrombosis / complications*,  diagnosis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin...
Next Document:  Microcoil Embolisation of Mycotic Cystic Artery Pseudoaneurysm: A Viable Option in High-Risk Patient...